Award
NIH Reporter #1P50HD123367-01
In vitro, ex vivo and in vivo Efficacy Core
Recipient
Weill Medical College of Cornell University
Award Amount
$420,951.00
Ceiling
$420,951.00
Awarded
September 10, 2026
Identifier
1P50HD123367-01
The award funds the development of assays to test the efficacy of sAC inhibitors for male contraception, supporting progression to clinical trials.
Description
This grant supports the development of assays to evaluate the efficacy of soluble adenylyl cyclase inhibitors as male contraceptives, aiming to progress into first-in-human trials.